Protara Therapeutics, Inc.

NASDAQ (USD): Protara Therapeutics, Inc. (TARA)

Last Price

4.55

Today's Change

-0.08 (1.72%)

Day's Change

4.51 - 4.66

Trading Volume

235,639

Overview

Market Cap

156 Million

Shares Outstanding

34 Million

Avg Volume

2,410,313

Avg Price (50 Days)

4.29

Avg Price (200 Days)

2.86

PE Ratio

-1.72

EPS

-2.64

Earnings Announcement

11-Mar-2025

Previous Close

4.63

Open

4.56

Day's Range

4.51 - 4.66

Year Range

1.595 - 10.48

Trading Volume

235,639

Price Change Highlight

1 Day Change

-1.73%

5 Day Change

-16.82%

1 Month Change

-11.82%

3 Month Change

138.22%

6 Month Change

101.33%

Ytd Change

-18.46%

1 Year Change

112.62%

3 Year Change

-25.65%

5 Year Change

-83.94%

10 Year Change

-99.01%

Max Change

-98.87%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment